Hepatitis clinical trials

Explore recruiting hepatitis clinical trials.

Recruiting hepatitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hepatitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2a, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BJT-778 in Healthy Volunteers and in Subjects with Chronic Hepatitis B Infection, Including Subjects with Chronic Hepatitis D Infection

Bulgaria, Romania, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

TherVacB – A multi-center phase 1b/2a trial to assess safety, tolerability and immunogenicity of a heterologous protein prime/MVA boost therapeutic hepatitis B vaccine candidate

Germany, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A study to determine the safety and effect of antibodies against hepatitis D (the SAMBA-D study)

Germany, Denmark

Human Pharmacology (Phase I)- Other EU CTIS Study details

Utility of the use of N-acetylcysteine associated with conventional treatment in patients with severe acute alcoholic hepatitis (Maddrey>=32)

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy of Ursodeoxycholic Acid versus Corticosteroids for the Treatment of Cholestatic Hepatitis Secondary to Immunotherapy: A Multicenter, Controlled, Randomized, Open Trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Effect of Alpha-1 Antitrypsin Supplementation in Alcohol-Associated Hepatitis-A prospective Pilot Study

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Hepatitis trials by city

Hepatitis in Toronto Hepatitis in Vancouver Hepatitis in Montreal Hepatitis in Calgary Hepatitis in Edmonton Hepatitis in Ottawa Hepatitis in Winnipeg Hepatitis in Quebec City Hepatitis in Hamilton Hepatitis in Kitchener Hepatitis in London Hepatitis in Halifax Hepatitis in New York Hepatitis in Los Angeles Hepatitis in Chicago Hepatitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease